| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 1.51e-09 | 38 | 181 | 8 | GO:0000146 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF13B MYH6 MYH7 MYH9 MYH10 MYH11 ABCA4 ERCC6 MYO5B ABCA13 MSH5 ABCA8 DDX5 MLH3 ABCA5 MYH14 DNAH17 SHPRH NAV3 ATP11A TNNT2 DHX29 DNAH9 | 8.90e-09 | 614 | 181 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | KIF13B MYH6 MYH7 MYH9 MYH10 MYH11 MYO5B MYH14 DNAH17 TNNT2 DNAH9 | 1.03e-08 | 118 | 181 | 11 | GO:0003774 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF13B MYH6 MYH7 MYH9 MYH10 MYH11 MYO5B MARK3 EML4 CAPZB TMOD2 GBP1 NEB DCTN1 TUBGCP6 CLIP3 SAG MYH14 TRIM32 FAM161A NAV3 RP1 DAAM1 PLEC TNNT2 AKAP1 | 6.93e-06 | 1099 | 181 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | actin filament binding | 4.39e-05 | 227 | 181 | 10 | GO:0051015 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF13B MYH7 ABCA4 ERCC6 MYO5B ABCA13 ABCA8 DDX5 MLH3 ABCA5 NAV3 ATP11A DHX29 DNAH9 | 5.20e-05 | 441 | 181 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | actin binding | MYH6 MYH7 MYH9 MYH10 MYH11 MYO5B CAPZB TMOD2 GBP1 NEB MYH14 DAAM1 PLEC TNNT2 | 1.25e-04 | 479 | 181 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF13B MYH7 ABCA4 ERCC6 MYO5B ABCA13 GBP1 SAR1A ABCA8 DDX5 MLH3 ABCA5 NAV3 MFN2 ATP11A GFM1 DHX29 DNAH9 | 2.49e-04 | 775 | 181 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | protein kinase binding | KIF13B BCL2L14 MYH6 MYH9 SASH1 NBEAL1 GRK5 BLNK PDPK2P DCTN1 LYST SH2B1 AURKA MLKL TJP2 ELAVL1 PLEK AKAP1 VDAC1 | 3.77e-04 | 873 | 181 | 19 | GO:0019901 |
| GeneOntologyMolecularFunction | beta-adrenergic receptor kinase activity | 4.84e-04 | 4 | 181 | 2 | GO:0047696 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF13B MYH7 ABCA4 ERCC6 MYO5B ABCA13 GBP1 SAR1A ABCA8 DDX5 MLH3 ABCA5 NAV3 MFN2 ATP11A GFM1 DHX29 DNAH9 | 6.37e-04 | 839 | 181 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF13B MYH7 ABCA4 ERCC6 MYO5B ABCA13 GBP1 SAR1A ABCA8 DDX5 MLH3 ABCA5 NAV3 MFN2 ATP11A GFM1 DHX29 DNAH9 | 6.46e-04 | 840 | 181 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF13B MYH7 ABCA4 ERCC6 MYO5B ABCA13 GBP1 SAR1A ABCA8 DDX5 MLH3 ABCA5 NAV3 MFN2 ATP11A GFM1 DHX29 DNAH9 | 6.46e-04 | 840 | 181 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 8.59e-04 | 47 | 181 | 4 | GO:0004712 | |
| GeneOntologyMolecularFunction | ADP binding | 9.31e-04 | 48 | 181 | 4 | GO:0043531 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.01e-03 | 49 | 181 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.22e-03 | 230 | 181 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | kinase binding | KIF13B BCL2L14 MYH6 MYH9 SASH1 NBEAL1 GRK5 BLNK PDPK2P DCTN1 LYST SH2B1 AURKA MLKL TJP2 ELAVL1 PLEK AKAP1 VDAC1 | 1.31e-03 | 969 | 181 | 19 | GO:0019900 |
| GeneOntologyMolecularFunction | mRNA 5'-UTR binding | 1.45e-03 | 25 | 181 | 3 | GO:0048027 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 1.67e-03 | 7 | 181 | 2 | GO:0090555 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor kinase activity | 1.67e-03 | 7 | 181 | 2 | GO:0004703 | |
| GeneOntologyMolecularFunction | ribosomal protein S6 kinase activity | 1.67e-03 | 7 | 181 | 2 | GO:0004711 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 6.20e-08 | 86 | 180 | 9 | GO:0030239 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 8.38e-08 | 89 | 180 | 9 | GO:0055002 | |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 1.16e-06 | 156 | 180 | 10 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 1.16e-06 | 156 | 180 | 10 | GO:0010927 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 8.50e-06 | 239 | 180 | 11 | GO:0031032 | |
| GeneOntologyBiologicalProcess | sarcomere organization | 1.25e-05 | 59 | 180 | 6 | GO:0045214 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 3.80e-05 | 105 | 180 | 7 | GO:1901879 | |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | MYH6 MYH7 MYH9 MYH10 MYH11 TMOD2 NEB DOCK5 TRIM32 MFN2 ATP11A PLEC TNNT2 | 4.14e-05 | 391 | 180 | 13 | GO:0051146 |
| GeneOntologyBiologicalProcess | muscle cell differentiation | CFH MYH6 TSHZ3 MYH7 MYH9 MYH10 MYH11 TMOD2 NEB DOCK5 TRIM32 MFN2 ATP11A PLEC TNNT2 | 6.84e-05 | 531 | 180 | 15 | GO:0042692 |
| GeneOntologyBiologicalProcess | platelet maturation | 7.57e-05 | 2 | 180 | 2 | GO:0036345 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | MYH6 MYH7 MYH10 MYH11 TMOD2 NEB TUBGCP6 DOCK5 AURKA AURKC MFN2 PLEC TNNT2 DHX29 | 7.68e-05 | 475 | 180 | 14 | GO:0140694 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | COL5A2 MYH6 MYH7 MYH9 MYH10 MYH11 MYO5B EML4 CAPZB TMOD2 NEB DCTN1 TUBGCP6 USP8 CLIP3 NAV3 MFN2 RP1 PLEC PLEK TNNT2 | 9.70e-05 | 957 | 180 | 21 | GO:0097435 |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 1.30e-04 | 89 | 180 | 6 | GO:1901880 | |
| GeneOntologyBiologicalProcess | negative regulation of dendrite development | 1.36e-04 | 12 | 180 | 3 | GO:2000171 | |
| GeneOntologyBiologicalProcess | actin filament bundle distribution | 2.26e-04 | 3 | 180 | 2 | GO:0070650 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYH6 MYH7 MYH9 MYH10 MYH11 MYO5B CYTH2 CAPZB TMOD2 NEB GRID2IP MYH14 TRIM32 MFN2 DAAM1 PLEC PLEK TNNT2 | 2.42e-04 | 803 | 180 | 18 | GO:0030036 |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 2.46e-04 | 100 | 180 | 6 | GO:0043242 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 2.75e-04 | 15 | 180 | 3 | GO:0030049 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 2.76e-04 | 144 | 180 | 7 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 2.76e-04 | 144 | 180 | 7 | GO:0043244 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 3.12e-04 | 194 | 180 | 8 | GO:0051494 | |
| GeneOntologyCellularComponent | myosin filament | 1.27e-09 | 25 | 179 | 7 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 1.17e-07 | 28 | 179 | 6 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin II filament | 6.17e-07 | 3 | 179 | 3 | GO:0097513 | |
| GeneOntologyCellularComponent | myosin complex | 7.03e-07 | 59 | 179 | 7 | GO:0016459 | |
| GeneOntologyCellularComponent | supramolecular fiber | KIF13B COL5A2 MYH6 MYH7 MYH9 MYH10 MYH11 EML4 CAPZB TMOD2 NEB DCTN1 TUBGCP6 AURKA AURKC CLIP3 PARP4 MYH14 TRIM32 FAM161A RASSF1 DNAH17 NAV3 SCO1 RP1 PLEC TNNT2 DNAH9 | 8.99e-07 | 1179 | 179 | 28 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KIF13B COL5A2 MYH6 MYH7 MYH9 MYH10 MYH11 EML4 CAPZB TMOD2 NEB DCTN1 TUBGCP6 AURKA AURKC CLIP3 PARP4 MYH14 TRIM32 FAM161A RASSF1 DNAH17 NAV3 SCO1 RP1 PLEC TNNT2 DNAH9 | 1.03e-06 | 1187 | 179 | 28 | GO:0099081 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 3.81e-05 | 107 | 179 | 7 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 3.81e-05 | 107 | 179 | 7 | GO:0001725 | |
| GeneOntologyCellularComponent | actomyosin | 6.74e-05 | 117 | 179 | 7 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 7.12e-05 | 118 | 179 | 7 | GO:0032432 | |
| GeneOntologyCellularComponent | postsynaptic specialization | CYTH2 CAPZB DGKB GRID1 PDPK2P DCC AURKA USP8 GRID2IP P2RY1 ROBO2 BSN AKAP1 VDAC1 | 1.15e-04 | 503 | 179 | 14 | GO:0099572 |
| GeneOntologyCellularComponent | organelle outer membrane | 1.52e-04 | 279 | 179 | 10 | GO:0031968 | |
| GeneOntologyCellularComponent | myofilament | 1.55e-04 | 32 | 179 | 4 | GO:0036379 | |
| GeneOntologyCellularComponent | outer membrane | 1.61e-04 | 281 | 179 | 10 | GO:0019867 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.08e-04 | 290 | 179 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | microtubule | KIF13B EML4 DCTN1 TUBGCP6 AURKA AURKC CLIP3 PARP4 FAM161A RASSF1 DNAH17 NAV3 RP1 DNAH9 | 2.09e-04 | 533 | 179 | 14 | GO:0005874 |
| GeneOntologyCellularComponent | axon | CFH KIF13B TSHZ3 MYH10 DTNA CYTH2 TMOD2 NFASC DCC DCTN1 DSCAML1 AURKA IGF2BP1 MYH14 SNX18 ROBO2 PLEC BSN SLC17A6 | 2.39e-04 | 891 | 179 | 19 | GO:0030424 |
| GeneOntologyCellularComponent | mitochondrial outer membrane | 2.41e-04 | 241 | 179 | 9 | GO:0005741 | |
| GeneOntologyCellularComponent | muscle myosin complex | 3.19e-04 | 16 | 179 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | brush border | 3.42e-04 | 152 | 179 | 7 | GO:0005903 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH6 MYH7 MYH9 MYH10 MYH11 MYO5B CAPZB TMOD2 GBP1 NEB DOCK5 MYH14 DAAM1 TNNT2 | 4.57e-04 | 576 | 179 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | postsynapse | MYH10 MYO5B CYTH2 RPS6KB1 CAPZB DGKB GRID1 RPS21 PDPK2P DCC AURKA USP8 IGF2BP1 GRID2IP P2RY1 ELAVL1 ROBO2 BSN AKAP1 VDAC1 | 4.71e-04 | 1018 | 179 | 20 | GO:0098794 |
| GeneOntologyCellularComponent | microtubule associated complex | 4.84e-04 | 161 | 179 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | postsynaptic density | CAPZB DGKB GRID1 PDPK2P DCC AURKA USP8 GRID2IP P2RY1 ROBO2 BSN VDAC1 | 5.31e-04 | 451 | 179 | 12 | GO:0014069 |
| GeneOntologyCellularComponent | meiotic spindle | 5.41e-04 | 19 | 179 | 3 | GO:0072687 | |
| GeneOntologyCellularComponent | myofibril | 5.96e-04 | 273 | 179 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 6.93e-04 | 223 | 179 | 8 | GO:0098862 | |
| GeneOntologyCellularComponent | asymmetric synapse | CAPZB DGKB GRID1 PDPK2P DCC AURKA USP8 GRID2IP P2RY1 ROBO2 BSN VDAC1 | 8.67e-04 | 477 | 179 | 12 | GO:0032279 |
| GeneOntologyCellularComponent | chromosome passenger complex | 1.07e-03 | 6 | 179 | 2 | GO:0032133 | |
| GeneOntologyCellularComponent | growth cone | 1.27e-03 | 245 | 179 | 8 | GO:0030426 | |
| GeneOntologyCellularComponent | sarcomere | 1.41e-03 | 249 | 179 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | striated muscle thin filament | 1.55e-03 | 27 | 179 | 3 | GO:0005865 | |
| GeneOntologyCellularComponent | site of polarized growth | 1.56e-03 | 253 | 179 | 8 | GO:0030427 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | CAPZB DGKB GRID1 PDPK2P DCC AURKA USP8 GRID2IP P2RY1 ROBO2 BSN VDAC1 | 1.89e-03 | 523 | 179 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | symbiont cell surface | 1.97e-03 | 8 | 179 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.97e-03 | 8 | 179 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | other organism part | 2.52e-03 | 9 | 179 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | spindle | MYH9 MYH10 EML4 RPS6KA2 DCTN1 TUBGCP6 AURKA AURKC PARP4 FAM161A RASSF1 | 2.53e-03 | 471 | 179 | 11 | GO:0005819 |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 2.62e-03 | 67 | 179 | 4 | GO:0031093 | |
| GeneOntologyCellularComponent | sarcoplasm | 3.01e-03 | 114 | 179 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 3.14e-03 | 10 | 179 | 2 | GO:0044614 | |
| GeneOntologyCellularComponent | mitochondrial membrane | PTPMT1 ACADL RPS6KB1 APOOL CPT1A ABCA8 HIGD1A MGST1 IKBKE CYB5R3 SCO1 MFN2 PLEC AKAP1 SDHA VDAC1 | 3.23e-03 | 866 | 179 | 16 | GO:0031966 |
| GeneOntologyCellularComponent | cell leading edge | MYH9 MYH10 CYTH3 CYTH2 CAPZB DCTN1 TMEM87A SH2B1 IGF2BP1 ROBO2 PLEK | 3.98e-03 | 500 | 179 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | microtubule end | 4.18e-03 | 38 | 179 | 3 | GO:1990752 | |
| GeneOntologyCellularComponent | outer dynein arm | 4.55e-03 | 12 | 179 | 2 | GO:0036157 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic specialization membrane | 4.55e-03 | 12 | 179 | 2 | GO:0098892 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KIF13B MYH9 EML4 DCTN1 TUBGCP6 AURKA AURKC CLIP3 PARP4 FAM161A RASSF1 DNAH17 NAV3 RP1 PLEC DNAH9 | 4.63e-03 | 899 | 179 | 16 | GO:0099513 |
| MousePheno | increased tumor incidence | RGPD4 BCL2L14 ERCC6 SPI1 ARID4A MAP3K8 BLNK MSH5 DCC LYST BAP1 AURKA MYH14 RASSF1 PCSK6 RGPD3 ATP11A ALDH2 | 1.81e-05 | 530 | 152 | 18 | MP:0002020 |
| Domain | Myosin_N | 3.21e-09 | 15 | 178 | 6 | PF02736 | |
| Domain | Myosin_N | 3.21e-09 | 15 | 178 | 6 | IPR004009 | |
| Domain | Myosin_tail_1 | 1.16e-08 | 18 | 178 | 6 | PF01576 | |
| Domain | Myosin_tail | 1.16e-08 | 18 | 178 | 6 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 1.69e-08 | 19 | 178 | 6 | IPR027401 | |
| Domain | - | 1.69e-08 | 19 | 178 | 6 | 4.10.270.10 | |
| Domain | Myosin_head_motor_dom | 6.24e-08 | 38 | 178 | 7 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 6.24e-08 | 38 | 178 | 7 | PS51456 | |
| Domain | Myosin_head | 6.24e-08 | 38 | 178 | 7 | PF00063 | |
| Domain | MYSc | 6.24e-08 | 38 | 178 | 7 | SM00242 | |
| Domain | P-loop_NTPase | KIF13B MYH6 MYH7 MYH9 MYH10 MYH11 ABCA4 ERCC6 MYO5B ABCA13 GBP1 MSH5 SLFN14 SAR1A ABCA8 DDX5 ABCA5 SBNO1 MYH14 SHPRH NAV3 TJP2 MFN2 GFM1 DHX29 DNAH9 | 1.37e-07 | 848 | 178 | 26 | IPR027417 |
| Domain | Teashirt_fam | 8.51e-07 | 3 | 178 | 3 | IPR027008 | |
| Domain | ABC_A | 3.72e-06 | 12 | 178 | 4 | IPR026082 | |
| Domain | Myosin_S1_N | 8.39e-06 | 5 | 178 | 3 | IPR008989 | |
| Domain | IQ | 1.22e-05 | 81 | 178 | 7 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 2.44e-05 | 90 | 178 | 7 | IPR000048 | |
| Domain | IQ | 3.02e-05 | 93 | 178 | 7 | PS50096 | |
| Domain | IQ | 5.90e-05 | 71 | 178 | 6 | PF00612 | |
| Domain | CAP_GLY | 9.72e-05 | 10 | 178 | 3 | PF01302 | |
| Domain | CAP_GLY | 9.72e-05 | 10 | 178 | 3 | SM01052 | |
| Domain | - | 9.72e-05 | 10 | 178 | 3 | 2.30.30.190 | |
| Domain | CAP_GLY_1 | 9.72e-05 | 10 | 178 | 3 | PS00845 | |
| Domain | CAP_GLY_2 | 9.72e-05 | 10 | 178 | 3 | PS50245 | |
| Domain | CAP-Gly_domain | 9.72e-05 | 10 | 178 | 3 | IPR000938 | |
| Domain | UCP038083_PDZ | 2.69e-04 | 3 | 178 | 2 | IPR017379 | |
| Domain | Aur | 2.69e-04 | 3 | 178 | 2 | IPR030616 | |
| Domain | - | ABCA4 ERCC6 ABCA13 GBP1 MSH5 SLFN14 SAR1A ABCA8 DDX5 ABCA5 SBNO1 SHPRH NAV3 TJP2 MFN2 GFM1 DHX29 DNAH9 | 2.85e-04 | 746 | 178 | 18 | 3.40.50.300 |
| Domain | - | 3.56e-04 | 15 | 178 | 3 | 1.10.1000.11 | |
| Domain | Sec7 | 3.56e-04 | 15 | 178 | 3 | PF01369 | |
| Domain | Sec7_alpha_orthog | 3.56e-04 | 15 | 178 | 3 | IPR023394 | |
| Domain | SEC7 | 4.35e-04 | 16 | 178 | 3 | PS50190 | |
| Domain | Sec7 | 4.35e-04 | 16 | 178 | 3 | SM00222 | |
| Domain | Sec7_dom | 4.35e-04 | 16 | 178 | 3 | IPR000904 | |
| Domain | PH_dom-like | RGPD4 NBEAL1 CYTH3 CYTH2 LYST SH2B1 RGPD3 PARP9 PLEK PLCH1 CYTH4 ARAP2 | 8.16e-04 | 426 | 178 | 12 | IPR011993 |
| Domain | ZnF_Rad18 | 8.86e-04 | 5 | 178 | 2 | SM00734 | |
| Domain | Znf_Rad18_put | 8.86e-04 | 5 | 178 | 2 | IPR006642 | |
| Domain | ABC_tran | 1.12e-03 | 48 | 178 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.12e-03 | 48 | 178 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.21e-03 | 49 | 178 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 1.30e-03 | 50 | 178 | 4 | IPR003439 | |
| Domain | PH_BEACH | 1.32e-03 | 6 | 178 | 2 | PF14844 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 2.63e-05 | 17 | 150 | 4 | M2482 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 4.22e-05 | 19 | 150 | 4 | M27493 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 4.22e-05 | 19 | 150 | 4 | M27489 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 5.23e-05 | 20 | 150 | 4 | M18415 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 6.40e-05 | 21 | 150 | 4 | M27494 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 9.32e-05 | 23 | 150 | 4 | MM15222 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 9.83e-05 | 70 | 150 | 6 | M12294 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 1.11e-04 | 24 | 150 | 4 | M2243 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 2.38e-04 | 116 | 150 | 7 | MM15715 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 2.38e-04 | 29 | 150 | 4 | M27309 | |
| Pubmed | RGPD4 KIF13B MYH6 MYH7 MYH9 MYH10 MYH11 MYO5B DTNA GRK5 GRK6 CAPZB DCC NEB TTC3 DCTN1 LYST DDX5 USP8 SBNO1 MYH14 FAM161A RGPD3 CYB5R3 ATP11A IFT122 ALDH2 PLEC BSN PLCH1 USPL1 PCDHGA8 SLC17A6 | 7.32e-13 | 1442 | 181 | 33 | 35575683 | |
| Pubmed | 1.65e-11 | 12 | 181 | 6 | 8424456 | ||
| Pubmed | 3.91e-10 | 54 | 181 | 8 | 22266860 | ||
| Pubmed | 7.10e-10 | 4 | 181 | 4 | 8482409 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYH10 KCNH8 TSHZ2 MARK3 DTNA VPS45 RPS6KA2 RPS6KB1 BLNK NFASC G2E3 MSH5 CPT1A TTC3 SH2B1 ADGRG6 DOCK5 PTPRB MYH14 NEMF SHPRH ATP11A IFT122 RERE DAAM1 POLK LSM7 ZMYM4 RAVER1 | 9.26e-10 | 1489 | 181 | 29 | 28611215 |
| Pubmed | 1.37e-09 | 92 | 181 | 9 | 37343697 | ||
| Pubmed | 3.53e-09 | 5 | 181 | 4 | 33871354 | ||
| Pubmed | 3.53e-09 | 45 | 181 | 7 | 22114352 | ||
| Pubmed | MYH6 MYH9 MYH10 MYH11 ACADL MYO5B MARK3 VPS45 CYTH2 CAPZB TMOD2 DGKB NFASC DCTN1 DDX5 MYH14 TJP2 ELAVL1 ALDH2 FGG PLEC BSN PLCH1 TNNT2 DHX29 SDHA VDAC1 | 7.36e-09 | 1431 | 181 | 27 | 37142655 | |
| Pubmed | A2M FAT4 MYH7 MYH9 CAPZB DCTN1 DDX5 DMAP1 DOCK5 USP8 CLIP3 IGF2BP3 MGST1 SHPRH ELAVL1 AKAP1 ZMYM4 SDHA VDAC1 | 1.78e-08 | 754 | 181 | 19 | 35906200 | |
| Pubmed | 2.45e-08 | 7 | 181 | 4 | 21126233 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | A2M RGPD4 MYH6 MYH7 MYH9 MYH10 MYH11 CAPZB TMOD2 DCTN1 SAR1A IGF2BP3 MYH14 TRIM32 DAAM1 PLEC SDHA | 5.74e-08 | 647 | 181 | 17 | 26618866 |
| Pubmed | FAT4 MYH9 ERCC6 ABCA13 RPS21 NEB PHC2 DOCK5 IGF2BP1 IGF2BP3 RGPD3 ELAVL1 FGG USPL1 ZMYM4 | 9.14e-08 | 513 | 181 | 15 | 25798074 | |
| Pubmed | 1.39e-07 | 3 | 181 | 3 | 8620598 | ||
| Pubmed | 1.39e-07 | 3 | 181 | 3 | 20685736 | ||
| Pubmed | 1.39e-07 | 3 | 181 | 3 | 15177565 | ||
| Pubmed | Teashirt 3 expression in the chick embryo reveals a remarkable association with tendon development. | 1.39e-07 | 3 | 181 | 3 | 16631416 | |
| Pubmed | 1.39e-07 | 3 | 181 | 3 | 15774463 | ||
| Pubmed | Analysis of TSHZ2 and TSHZ3 genes in congenital pelvi-ureteric junction obstruction. | 1.39e-07 | 3 | 181 | 3 | 19745106 | |
| Pubmed | Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family. | 1.39e-07 | 3 | 181 | 3 | 14594953 | |
| Pubmed | 1.39e-07 | 3 | 181 | 3 | 14973285 | ||
| Pubmed | Characterization of three full-length human nonmuscle myosin II paralogs. | 1.39e-07 | 3 | 181 | 3 | 24072716 | |
| Pubmed | 1.39e-07 | 3 | 181 | 3 | 15845534 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | MYH6 MYH10 MYH11 SASH1 ACADL MYO5B RPS6KA2 CAPZB TMOD2 NFASC DCTN1 DDX5 MFN2 ALDH2 BSN VDAC1 | 1.87e-07 | 621 | 181 | 16 | 22794259 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYH9 MYH10 PTPMT1 EML4 CAPZB RPS21 CPT1A DCTN1 DDX5 YARS2 AURKA MLKL HIGD1A USP8 IGF2BP1 IGF2BP3 SBNO1 NEMF SCO1 ELAVL1 PLEC SDHA VDAC1 RAVER1 | 3.82e-07 | 1415 | 181 | 24 | 28515276 |
| Pubmed | 4.64e-07 | 234 | 181 | 10 | 36243803 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 10652308 | ||
| Pubmed | Cellular nonmuscle myosins NMHC-IIA and NMHC-IIB and vertebrate heart looping. | 5.52e-07 | 4 | 181 | 3 | 18697221 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | CFH KIF13B SERPINA3 MYH9 ABCA4 ARID4A INPP1 APOOL CAPZB GRXCR1 DCTN1 BAP1 SAG GSDME MYH14 RASSF1 DNAH17 SCO1 ATP11A ALDH2 GFM1 ARAP2 | 5.96e-07 | 1242 | 181 | 22 | 30973865 |
| Pubmed | 8.01e-07 | 61 | 181 | 6 | 27166947 | ||
| Pubmed | Myosin II regulates extension, growth and patterning in the mammalian cochlear duct. | 1.38e-06 | 5 | 181 | 3 | 19439495 | |
| Pubmed | Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and Notch signaling. | 1.38e-06 | 5 | 181 | 3 | 24091702 | |
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 12920129 | ||
| Pubmed | Cell-cell adhesions and cell contractility are upregulated upon desmosome disruption. | 1.38e-06 | 5 | 181 | 3 | 25006807 | |
| Pubmed | Telokin expression is restricted to smooth muscle tissues during mouse development. | 1.38e-06 | 5 | 181 | 3 | 11121372 | |
| Pubmed | Coordinated metabolic responses to cyclophilin D deletion in the developing heart. | 2.05e-06 | 18 | 181 | 4 | 38414851 | |
| Pubmed | KIF13B MYH11 MYO5B ZFP28 ABCA8 SH2B1 FAN1 PARP4 GLCE DNAH17 ATP11A TTC39A PLCH1 | 2.13e-06 | 493 | 181 | 13 | 15368895 | |
| Pubmed | 2.15e-06 | 72 | 181 | 6 | 34882091 | ||
| Pubmed | RGPD4 MYH9 MYH10 ACADL DTNA VPS45 CYTH2 RPS21 RGPD3 CYB5R3 NAV3 TJP2 DAAM1 PLEC BSN GFM1 ALDH6A1 DHX29 SDHA VDAC1 | 2.29e-06 | 1139 | 181 | 20 | 36417873 | |
| Pubmed | SERPINA3 MYH7 DTNA NEB TTC3 DCTN1 PARP4 GSDME MYH14 TRIM32 PLEC AKAP1 ZMYM4 | 2.32e-06 | 497 | 181 | 13 | 23414517 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYH9 MYH10 MYH11 CAPZB RPS21 THOC2 DCTN1 SAR1A DDX5 IGF2BP1 IGF2BP3 MYH14 SCO1 PLEC DHX29 SDHA VDAC1 | 2.39e-06 | 847 | 181 | 17 | 35235311 |
| Pubmed | 2.66e-06 | 116 | 181 | 7 | 30652415 | ||
| Pubmed | Nonmuscle myosin II regulation of lung epithelial morphology. | 2.74e-06 | 6 | 181 | 3 | 22972683 | |
| Pubmed | 2.74e-06 | 6 | 181 | 3 | 15034141 | ||
| Pubmed | 2.74e-06 | 6 | 181 | 3 | 30044719 | ||
| Pubmed | 2.74e-06 | 6 | 181 | 3 | 31365875 | ||
| Pubmed | 3.73e-06 | 295 | 181 | 10 | 26209609 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 3.76e-06 | 231 | 181 | 9 | 16452087 | |
| Pubmed | CFH VPS45 CYTH3 TTC3 DCTN1 DSCAML1 SH2B1 DMAP1 FAN1 USP8 SBNO1 MYH14 TRIM32 PCSK6 NEMF NAV3 IFT122 PLEC USPL1 ZMYM4 SDHA | 3.86e-06 | 1285 | 181 | 21 | 35914814 | |
| Pubmed | Myocardial Mycn is essential for mouse ventricular wall morphogenesis. | 3.96e-06 | 21 | 181 | 4 | 23063798 | |
| Pubmed | 4.03e-06 | 233 | 181 | 9 | 29518331 | ||
| Pubmed | FE65 binds Teashirt, inhibiting expression of the primate-specific caspase-4. | 4.78e-06 | 7 | 181 | 3 | 19343227 | |
| Pubmed | Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity. | 4.78e-06 | 7 | 181 | 3 | 22510986 | |
| Pubmed | Nonmuscle myosin II isoform and domain specificity during early mouse development. | 4.78e-06 | 7 | 181 | 3 | 20679233 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RGPD4 MYH7 MYH9 MYH10 CAPZB SAR1A DDX5 IGF2BP1 IGF2BP3 MYH14 RGPD3 TJP2 ELAVL1 PLEC | 5.73e-06 | 626 | 181 | 14 | 33644029 |
| Pubmed | 6.33e-06 | 50 | 181 | 5 | 37001908 | ||
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | MORC1 MYH9 MYH10 CAPZB DDX5 ABCA5 CYB5R3 TJP2 MFN2 ELAVL1 PLEC VDAC1 | 7.02e-06 | 468 | 181 | 12 | 36042349 |
| Pubmed | MYH9 MYH10 MYH11 ABCA4 CAPZB TMOD2 DCTN1 DDX5 SAG MYH14 ELAVL1 SDHA VDAC1 | 7.21e-06 | 552 | 181 | 13 | 36293380 | |
| Pubmed | Convergence and extrusion are required for normal fusion of the mammalian secondary palate. | 7.62e-06 | 8 | 181 | 3 | 25848986 | |
| Pubmed | Loss of cell adhesion causes hydrocephalus in nonmuscle myosin II-B-ablated and mutated mice. | 7.62e-06 | 8 | 181 | 3 | 17429076 | |
| Pubmed | 7.62e-06 | 8 | 181 | 3 | 17398095 | ||
| Pubmed | 7.62e-06 | 8 | 181 | 3 | 33424621 | ||
| Pubmed | 7.62e-06 | 8 | 181 | 3 | 15834955 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | MYH9 ARID4A MARK3 CYTH3 CYTH2 RPS6KB1 MSH5 THOC2 TTC3 DCTN1 DDX5 YARS2 FAN1 AURKA GSDME POLK DHX29 | 7.63e-06 | 925 | 181 | 17 | 28986522 |
| Pubmed | 7.76e-06 | 191 | 181 | 8 | 33762435 | ||
| Pubmed | 8.24e-06 | 25 | 181 | 4 | 32913122 | ||
| Pubmed | A2M RGPD4 SERPINA3 MYH9 ABCA13 CAPZB THOC2 DDX5 IGF2BP3 MYH14 ELAVL1 ALDH2 PLEC VDAC1 | 9.07e-06 | 652 | 181 | 14 | 31180492 | |
| Pubmed | 1.02e-05 | 331 | 181 | 10 | 29199018 | ||
| Pubmed | Numb family proteins are essential for cardiac morphogenesis and progenitor differentiation. | 1.13e-05 | 27 | 181 | 4 | 24335256 | |
| Pubmed | DNA cross-link repair safeguards genomic stability during premeiotic germ cell development. | 1.14e-05 | 9 | 181 | 3 | 31367016 | |
| Pubmed | 1.17e-05 | 202 | 181 | 8 | 24639526 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH7 MYH9 MYH10 MARK3 EML4 CAPZB DGKB DCTN1 DDX5 YARS2 AURKA MLKL HIGD1A USP8 IGF2BP1 IGF2BP3 IKBKE STEEP1 TJP2 VDAC1 | 1.34e-05 | 1284 | 181 | 20 | 17353931 |
| Pubmed | RGPD4 TSHZ3 MYH9 DCTN1 BAP1 RGPD3 CYB5R3 RERE PLEC AKAP1 ZMYM4 | 1.34e-05 | 418 | 181 | 11 | 34709266 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ARID4A EML4 THOC2 PHC2 BAP1 TUBGCP6 TJP2 RERE PLEC AKAP1 DHX29 ZMYM4 CYTH4 VDAC1 RAVER1 | 1.45e-05 | 774 | 181 | 15 | 15302935 |
| Pubmed | CFH PNLIPRP1 SPI1 MAP3K8 RPS6KB1 GCNT1 PRSS23 NEB TTC3 DDX5 FAN1 AURKA HIGD1A IGF2BP1 PARP9 ZNF85 DAAM1 PLEC RCAN2 CYTH4 | 1.48e-05 | 1293 | 181 | 20 | 15342556 | |
| Pubmed | HAND2-mediated epithelial maintenance and integrity in cardiac outflow tract morphogenesis. | 1.52e-05 | 29 | 181 | 4 | 31201155 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MYH9 MYH10 APOOL CAPZB THOC2 DDX5 PHC2 DMAP1 IGF2BP1 IGF2BP3 MGST1 TRIM32 NEMF CYB5R3 ELAVL1 PLEC LSM7 VDAC1 | 1.56e-05 | 1082 | 181 | 18 | 38697112 |
| Pubmed | A Non-canonical PDK1-RSK Signal Diminishes Pro-caspase-8-Mediated Necroptosis Blockade. | 1.62e-05 | 10 | 181 | 3 | 32979304 | |
| Pubmed | A point mutation in Myh10 causes major defects in heart development and body wall closure. | 1.62e-05 | 10 | 181 | 3 | 24825879 | |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 1.63e-05 | 102 | 181 | 6 | 15778465 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH9 MYH10 CAPZB THOC2 TTC3 DCTN1 SAR1A DDX5 YARS2 IGF2BP1 SBNO1 MYH14 NEMF CYB5R3 ELAVL1 ALDH2 BSN GFM1 DHX29 SDHA VDAC1 | 1.83e-05 | 1425 | 181 | 21 | 30948266 |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 1.84e-05 | 62 | 181 | 5 | 28344315 | |
| Pubmed | 2.00e-05 | 31 | 181 | 4 | 21985497 | ||
| Pubmed | MYH9 MYH10 ARID4A MARK3 DCTN1 SAR1A DDX5 DMAP1 BAP1 YARS2 AURKA AURKC SBNO1 GLCE STEEP1 MFN2 ELAVL1 RERE ZMYM4 VDAC1 | 2.14e-05 | 1327 | 181 | 20 | 32694731 | |
| Pubmed | 2.22e-05 | 11 | 181 | 3 | 31286143 | ||
| Pubmed | MYH9 MYH10 CAPZB RPS21 THOC2 SAR1A DDX5 IGF2BP1 IGF2BP3 ELAVL1 PLEC SDHA VDAC1 RAVER1 | 2.22e-05 | 707 | 181 | 14 | 19738201 | |
| Pubmed | MARK3 EML4 DTNA RPS6KB1 CPT1A SAR1A PHC2 AURKA CLIP3 IGF2BP3 SAG FAM161A NAV3 PLEC BSN PLCH1 ZMYM4 | 2.23e-05 | 1006 | 181 | 17 | 15226823 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH6 MYH7 MARK3 EML4 DTNA RPS6KA2 RPS6KB1 DCTN1 SAR1A LYST AURKA MLKL AURKC IKBKE RASSF1 PLEC | 2.44e-05 | 910 | 181 | 16 | 36736316 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | SERPINA3 MYH9 MXRA5 GIPC2 MYO5B CAPZB NOX3 GRID1 NEB DDX5 PARP4 MYH14 SNX18 ROBO2 ALDH2 FGG VDAC1 | 2.53e-05 | 1016 | 181 | 17 | 19056867 |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 21792479 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 22328520 | ||
| Pubmed | Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. | 2.69e-05 | 2 | 181 | 2 | 15769782 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 21526716 | ||
| Pubmed | Nonmuscle myosin II-B is required for normal development of the mouse heart. | 2.69e-05 | 2 | 181 | 2 | 9356462 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 35255953 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 19109430 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 17020881 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 2726733 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 17563743 | ||
| Pubmed | Protein Complex of Fibrinogen Gamma Chain and Complement Factor H in Ovarian Cancer Patient Plasma. | 2.69e-05 | 2 | 181 | 2 | 28551622 | |
| Interaction | ECT2 interactions | COL5A2 MYH9 MYH10 MYH11 MYO5B ABCA13 MARK3 CAPZB TMOD2 RPS21 LYST DDX5 PARP4 IGF2BP1 IGF2BP3 MYH14 TRIM32 NAV3 TJP2 ELAVL1 PLEC GFM1 DNAH9 VDAC1 | 9.54e-07 | 887 | 177 | 24 | int:ECT2 |
| Interaction | PTP4A3 interactions | 9.02e-06 | 154 | 177 | 9 | int:PTP4A3 | |
| Interaction | PRKD2 interactions | MYH9 INPP1 BAP1 DOCK5 MYH14 TLE2 GLCE BRINP2 ELAVL1 ROBO2 ALDH2 | 1.59e-05 | 254 | 177 | 11 | int:PRKD2 |
| Interaction | CC2D1B interactions | 1.96e-05 | 38 | 177 | 5 | int:CC2D1B | |
| Interaction | TPM1 interactions | MYH6 MYH9 CAPZB TMOD2 NEB THOC2 BAP1 TRIM32 ELAVL1 TNNT2 VDAC1 | 2.19e-05 | 263 | 177 | 11 | int:TPM1 |
| Interaction | STX17 interactions | A2M CFH KIF13B SERPINA3 AURKA MLH3 MYH14 TJP2 FGG PLEC AKAP1 | 2.35e-05 | 265 | 177 | 11 | int:STX17 |
| Interaction | ABCA13 interactions | 2.50e-05 | 20 | 177 | 4 | int:ABCA13 | |
| Interaction | TRIM6 interactions | 4.41e-05 | 73 | 177 | 6 | int:TRIM6 | |
| Interaction | MYL3 interactions | 6.30e-05 | 25 | 177 | 4 | int:MYL3 | |
| Interaction | CNKSR1 interactions | 6.89e-05 | 49 | 177 | 5 | int:CNKSR1 | |
| Interaction | LTN1 interactions | 7.38e-05 | 201 | 177 | 9 | int:LTN1 | |
| Interaction | BCL2L2 interactions | 7.40e-05 | 80 | 177 | 6 | int:BCL2L2 | |
| Interaction | MXRA5 interactions | 7.64e-05 | 10 | 177 | 3 | int:MXRA5 | |
| Interaction | MYO19 interactions | 8.09e-05 | 252 | 177 | 10 | int:MYO19 | |
| Interaction | KCTD13 interactions | MYH6 MYH9 MYH10 MYH11 ACADL MYO5B MARK3 VPS45 CYTH2 CAPZB TMOD2 DGKB NFASC DCTN1 DDX5 MYH14 TJP2 ELAVL1 ALDH2 FGG PLEC BSN PLCH1 TNNT2 DHX29 SDHA VDAC1 | 8.64e-05 | 1394 | 177 | 27 | int:KCTD13 |
| Interaction | GAGE5 interactions | 9.19e-05 | 52 | 177 | 5 | int:GAGE5 | |
| Interaction | H2BC4 interactions | 1.01e-04 | 259 | 177 | 10 | int:H2BC4 | |
| Interaction | IPCEF1 interactions | 1.04e-04 | 11 | 177 | 3 | int:IPCEF1 | |
| GeneFamily | Myosin heavy chains | 7.68e-10 | 15 | 136 | 6 | 1098 | |
| GeneFamily | ATP binding cassette subfamily A | 2.89e-06 | 14 | 136 | 4 | 805 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.77e-04 | 15 | 136 | 3 | 529 | |
| GeneFamily | Actins|Deafness associated genes | 1.64e-03 | 113 | 136 | 5 | 1152 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.95e-03 | 9 | 136 | 2 | 1230 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | RPS6KA2 GCNT1 TTC3 ABCA8 ELAVL1 DAAM1 PLEC POLK AKAP1 RAVER1 | 1.33e-06 | 199 | 181 | 10 | M6264 |
| Coexpression | GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_DN | CFH MYH11 SASH1 MARK3 MAP3K8 RPS21 PRSS23 DDX5 NAA30 ALDH6A1 | 1.39e-06 | 200 | 181 | 10 | M6894 |
| Coexpression | MARTENS_BOUND_BY_PML_RARA_FUSION | MYH9 SPI1 RPS6KA2 GRK5 GRK6 DCTN1 SH2B1 DDX5 ELAVL1 ALDH2 PLEK EDRF1 CYTH4 RAVER1 | 3.77e-06 | 456 | 181 | 14 | M2094 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 1.56e-05 | 115 | 181 | 7 | M45752 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | CFH MYH9 NBEAL1 MAP3K8 FAT3 GRK5 GBP1 COL6A5 GCNT1 PRSS23 ABCA8 ADGRG6 DOCK5 MLKL MGST1 CYB5R3 PARP9 PLEK RCAN2 CYTH4 ARAP2 | 1.87e-06 | 778 | 175 | 21 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_100 | 5.67e-06 | 15 | 175 | 4 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_100 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.74e-05 | 136 | 175 | 8 | gudmap_kidney_adult_RenalCapsule_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#3_top-relative-expression-ranked_500 | 3.10e-05 | 73 | 175 | 6 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | COL5A2 FAT4 TSHZ3 MYH11 CALHM5 GIPC2 ARID4A EML4 GBP1 GCNT1 PRSS23 TSPAN2 ADGRG6 HIGD1A PTPRB ABCA5 ETAA1 TNNT2 ARAP2 | 5.42e-05 | 826 | 175 | 19 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_200 | 5.58e-05 | 160 | 175 | 8 | gudmap_developingKidney_e15.5_Podocyte cells_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_200 | 6.75e-05 | 27 | 175 | 4 | gudmap_developingLowerUrinaryTract_P1_ureter_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.36e-04 | 95 | 175 | 6 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#3_top-relative-expression-ranked_200 | 1.51e-04 | 33 | 175 | 4 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k3_200 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_500 | CFH GIPC2 FAT3 GCNT1 PRSS23 TSPAN2 ADGRG6 MEP1A MGST1 ROBO2 OTULINL PLCH1 | 1.66e-04 | 412 | 175 | 12 | gudmap_kidney_e15.5_Podocyte_MafB_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_500 | CFH MYH11 MYO5B GBP1 PRSS23 TSPAN2 DOCK5 PTPRB OTULINL PLEK PLCH1 TNNT2 | 1.77e-04 | 415 | 175 | 12 | gudmap_developingKidney_e15.5_Podocyte cells_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#3_top-relative-expression-ranked_100 | 1.87e-04 | 14 | 175 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_100_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | CFH MYH11 MYO5B DTNA MAP3K8 RPS6KB1 ZFP28 GBP1 GCNT1 PRSS23 TSPAN2 DOCK5 PTPRB ABCA5 OTULINL PLEK PLCH1 TNNT2 | 1.96e-04 | 836 | 175 | 18 | gudmap_developingKidney_e15.5_Podocyte cells_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | BCL2L14 SERPINA3 MYH7 MYH9 MYH11 CALHM5 ACADL DTNA GBP1 GCNT1 PRSS23 NEB TSPAN2 ADGRG6 MLKL TNNT2 ARAP2 | 2.28e-04 | 772 | 175 | 17 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000 | BCL2L14 MYH6 MYH7 MYH11 NBEAL1 GBP1 GCNT1 PRSS23 CPT1A TSPAN2 ADGRG6 MLKL PTPRB ABCA5 ALDH2 TNNT2 ARAP2 | 2.35e-04 | 774 | 175 | 17 | gudmap_developingLowerUrinaryTract_P1_ureter_1000 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_500 | CFH MYH9 MYH11 NBEAL1 DGKB GBP1 LYST MLKL PTPRB CYB5R3 RCAN2 ARAP2 | 2.40e-04 | 429 | 175 | 12 | gudmap_kidney_adult_Mesangium_Meis_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_500 | 2.61e-04 | 107 | 175 | 6 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M FAT4 ABCA4 ABCA13 FAT3 DGKB GRID1 ODAD2 DCC NEB DSCAML1 NAV3 PLCH1 DNAH9 | 3.40e-14 | 184 | 181 | 14 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M FAT4 ABCA4 ABCA13 FAT3 DGKB GRID1 ODAD2 DCC NEB DSCAML1 NAV3 PLCH1 DNAH9 | 3.40e-14 | 184 | 181 | 14 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M FAT4 ABCA4 ABCA13 FAT3 DGKB GRID1 ODAD2 DCC NEB DSCAML1 NAV3 PLCH1 DNAH9 | 3.40e-14 | 184 | 181 | 14 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.05e-10 | 191 | 181 | 11 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | A2M CFH MYH10 TSHZ2 GRK5 CAPZB NFASC PRSS23 ABCA8 DAAM1 RCAN2 | 4.78e-10 | 194 | 181 | 11 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | A2M CFH MYH10 TSHZ2 GRK5 CAPZB NFASC PRSS23 ABCA8 DAAM1 RCAN2 | 4.78e-10 | 194 | 181 | 11 | df82cce5ebeb73740b02cf816c6df82253cfd566 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | A2M CFH COL5A2 MYH11 TSHZ2 GRK5 NFASC PRSS23 ABCA8 DAAM1 RCAN2 | 5.63e-10 | 197 | 181 | 11 | 80e153790cef37b743e22a7370ff5b3a6abf147d |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | CFH COL5A2 FAT4 MYH10 TSHZ2 FAT3 GRK5 ADGRG6 IGF2BP1 IGF2BP3 ROBO2 | 6.26e-10 | 199 | 181 | 11 | 5b9d355795dd03a22f0961dfd143425c367a4654 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-09 | 160 | 181 | 10 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-09 | 160 | 181 | 10 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 5.28e-09 | 187 | 181 | 10 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.80e-09 | 192 | 181 | 10 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.89e-09 | 195 | 181 | 10 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.89e-09 | 195 | 181 | 10 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.89e-09 | 195 | 181 | 10 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 7.89e-09 | 195 | 181 | 10 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.28e-09 | 196 | 181 | 10 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 8.28e-09 | 196 | 181 | 10 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 8.69e-09 | 197 | 181 | 10 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.12e-09 | 198 | 181 | 10 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 9.57e-09 | 199 | 181 | 10 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-08 | 200 | 181 | 10 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.00e-08 | 200 | 181 | 10 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.00e-08 | 200 | 181 | 10 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-08 | 200 | 181 | 10 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-08 | 200 | 181 | 10 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-08 | 200 | 181 | 10 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | COL5A2 FAT4 MYH10 MYH11 TSHZ2 PRSS23 ADGRG6 DOCK5 ROBO2 TSHZ1 | 1.00e-08 | 200 | 181 | 10 | a799fc7bb83ad0524362cb5010df949741fb7bf3 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-08 | 200 | 181 | 10 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-08 | 200 | 181 | 10 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.00e-08 | 200 | 181 | 10 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-08 | 181 | 181 | 9 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-08 | 181 | 181 | 9 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 7.75e-08 | 187 | 181 | 9 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 8.88e-08 | 190 | 181 | 9 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.29e-08 | 191 | 181 | 9 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.29e-08 | 191 | 181 | 9 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.71e-08 | 192 | 181 | 9 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 9.71e-08 | 192 | 181 | 9 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.02e-07 | 193 | 181 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.06e-07 | 194 | 181 | 9 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-07 | 195 | 181 | 9 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.11e-07 | 195 | 181 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-07 | 195 | 181 | 9 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.11e-07 | 195 | 181 | 9 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.11e-07 | 195 | 181 | 9 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-07 | 196 | 181 | 9 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.16e-07 | 196 | 181 | 9 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-07 | 196 | 181 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-07 | 196 | 181 | 9 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-07 | 196 | 181 | 9 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-07 | 196 | 181 | 9 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-07 | 196 | 181 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.21e-07 | 197 | 181 | 9 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.21e-07 | 197 | 181 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.26e-07 | 198 | 181 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-07 | 198 | 181 | 9 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.26e-07 | 198 | 181 | 9 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.26e-07 | 198 | 181 | 9 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.26e-07 | 198 | 181 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-07 | 198 | 181 | 9 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.26e-07 | 198 | 181 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-07 | 199 | 181 | 9 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-07 | 199 | 181 | 9 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.32e-07 | 199 | 181 | 9 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-07 | 200 | 181 | 9 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 5.40e-07 | 172 | 181 | 8 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.64e-07 | 173 | 181 | 8 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.64e-07 | 173 | 181 | 8 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.61e-07 | 180 | 181 | 8 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.94e-07 | 181 | 181 | 8 | e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.62e-07 | 183 | 181 | 8 | f4ea7113ce9099222743d9ff02388d3d8a9e987b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.74e-07 | 186 | 181 | 8 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.01e-06 | 187 | 181 | 8 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.01e-06 | 187 | 181 | 8 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.06e-06 | 188 | 181 | 8 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.10e-06 | 189 | 181 | 8 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.10e-06 | 189 | 181 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-06 | 189 | 181 | 8 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-06 | 190 | 181 | 8 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-06 | 190 | 181 | 8 | 591310e615700321a010a4b90405cbbbbdb3aade | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-06 | 190 | 181 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-06 | 190 | 181 | 8 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.19e-06 | 191 | 181 | 8 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 191 | 181 | 8 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.19e-06 | 191 | 181 | 8 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.19e-06 | 191 | 181 | 8 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 191 | 181 | 8 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.19e-06 | 191 | 181 | 8 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.19e-06 | 191 | 181 | 8 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.24e-06 | 192 | 181 | 8 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 192 | 181 | 8 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 192 | 181 | 8 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 192 | 181 | 8 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 192 | 181 | 8 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-06 | 193 | 181 | 8 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.29e-06 | 193 | 181 | 8 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.29e-06 | 193 | 181 | 8 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-06 | 194 | 181 | 8 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-06 | 194 | 181 | 8 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| Drug | purealin | 1.79e-08 | 58 | 180 | 8 | CID006419303 | |
| Drug | formycin triphosphate | 1.48e-07 | 51 | 180 | 7 | CID000122274 | |
| Drug | N-ethylmaleimide | A2M SLC43A2 KIF13B MYH6 MYH7 MYH9 MYH10 MYH11 MYO5B DTNA VPS45 TG MGST1 MYH14 TRIM32 POLK GFM1 | 6.94e-07 | 511 | 180 | 17 | CID000004362 |
| Drug | fast white | 9.30e-07 | 42 | 180 | 6 | CID000024008 | |
| Drug | S-(-)-Etomoxir | 1.31e-06 | 100 | 180 | 8 | CID000060765 | |
| Drug | clenbuterol | 2.00e-06 | 142 | 180 | 9 | CID000002783 | |
| Drug | creatine | 3.33e-06 | 193 | 180 | 10 | CID000000586 | |
| Drug | Edrophonium chloride [116-38-1]; Up 200; 19.8uM; MCF7; HT_HG-U133A | 4.00e-06 | 197 | 180 | 10 | 5001_UP | |
| Drug | Bethanechol chloride [590-63-6]; Up 200; 20.4uM; PC3; HT_HG-U133A | FAT4 RPS6KA2 GRK6 SH2B1 SLC35D1 AURKC MYH14 RASSF1 ETAA1 BRINP2 | 4.18e-06 | 198 | 180 | 10 | 5114_UP |
| Drug | K-Cl | MYH6 MYH7 MYH9 MYH10 MYH11 KCNH8 MYO5B MARK3 YARS2 AURKA GSDME P2RY1 MYH14 ELAVL1 POLK VDAC1 | 1.20e-05 | 567 | 180 | 16 | CID000004873 |
| Drug | nocodazole | MYH6 MYH7 MYH9 MYH10 MYH11 MYO5B EML4 DCTN1 TG DOCK5 AURKA MYH14 RASSF1 CYB5R3 | 2.80e-05 | 477 | 180 | 14 | CID000004122 |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; PC3; HT_HG-U133A | 2.94e-05 | 198 | 180 | 9 | 4293_UP | |
| Drug | NSC339663 | 3.18e-05 | 250 | 180 | 10 | CID000003892 | |
| Drug | blebbistatin | 3.88e-05 | 116 | 180 | 7 | CID003476986 | |
| Drug | SecinH3 | 3.94e-05 | 9 | 180 | 3 | CID001029232 | |
| Drug | B0683 | 4.10e-05 | 117 | 180 | 7 | CID006398969 | |
| Drug | carvedilol | 4.38e-05 | 161 | 180 | 8 | CID000002585 | |
| Disease | Colorectal Carcinoma | ABCA4 ERCC6 ABCA13 RPS6KB1 SLC22A15 GRID1 DCC DSCAML1 ABCA8 AURKA MLH3 ABCA5 ETAA1 ALDH2 EDRF1 ZMYM4 | 4.54e-06 | 702 | 174 | 16 | C0009402 |
| Disease | Colorectal Neoplasms | ABCA4 ABCA13 SLC22A15 GRID1 DCC ABCA8 AURKA MLH3 ABCA5 ALDH2 | 6.31e-06 | 277 | 174 | 10 | C0009404 |
| Disease | Obstructive asymmetric septal hypertrophy | 6.93e-06 | 7 | 174 | 3 | C0597124 | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 6.93e-06 | 7 | 174 | 3 | C0700053 | |
| Disease | Hypertrophic obstructive cardiomyopathy | 1.34e-05 | 25 | 174 | 4 | C4551472 | |
| Disease | Limb-girdle muscular dystrophy | 1.58e-05 | 26 | 174 | 4 | cv:C0686353 | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 1.65e-05 | 9 | 174 | 3 | C0949658 | |
| Disease | Primary familial dilated cardiomyopathy | 2.84e-05 | 30 | 174 | 4 | cv:C0340427 | |
| Disease | PR interval | KIF13B MYH7 MYH11 ARID4A MARK3 EML4 DTNA DGKB MGST1 TTC39A PLEC RCAN2 | 4.08e-05 | 495 | 174 | 12 | EFO_0004462 |
| Disease | Primary dilated cardiomyopathy | 4.72e-05 | 34 | 174 | 4 | cv:C0007193 | |
| Disease | transmembrane protein 87B measurement | 5.52e-05 | 13 | 174 | 3 | EFO_0802158 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 6.40e-05 | 71 | 174 | 5 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Left ventricular noncompaction | 6.99e-05 | 14 | 174 | 3 | C1960469 | |
| Disease | venous thromboembolism, factor VII measurement | 7.37e-05 | 38 | 174 | 4 | EFO_0004286, EFO_0004619 | |
| Disease | autoimmune disease | 7.86e-05 | 173 | 174 | 7 | EFO_0005140 | |
| Disease | blood phosphate measurement | 8.15e-05 | 174 | 174 | 7 | EFO_0010972 | |
| Disease | Nonsyndromic genetic hearing loss | 8.87e-05 | 76 | 174 | 5 | cv:C5680182 | |
| Disease | calcium measurement | CFH SLC43A2 BCL2L14 GIPC2 GRK5 CPT1A DMAP1 SAG CYB5R3 PARP9 PLEC POLK AKAP1 | 9.70e-05 | 628 | 174 | 13 | EFO_0004838 |
| Disease | E3 ISG15--protein ligase HERC5 measurement | 1.03e-04 | 3 | 174 | 2 | EFO_0802501 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 1.10e-04 | 42 | 174 | 4 | EFO_0004286, EFO_0004629 | |
| Disease | Familial dilated cardiomyopathy | 1.32e-04 | 44 | 174 | 4 | C0340427 | |
| Disease | Age-related macular degeneration | 1.54e-04 | 18 | 174 | 3 | cv:C0242383 | |
| Disease | Cardiomyopathy | 1.71e-04 | 47 | 174 | 4 | cv:C0878544 | |
| Disease | platelet crit | SLC43A2 INPP1 CAPZB SLFN14 SLCO1B1 SBNO1 CYB5R3 NAV3 MFN2 RP1 RERE ALDH2 PLEC PLEK RCAN2 RAVER1 | 1.74e-04 | 952 | 174 | 16 | EFO_0007985 |
| Disease | Cardiomyopathy, Dilated | 1.86e-04 | 48 | 174 | 4 | C0007193 | |
| Disease | Cardiomyopathy, Familial Hypertrophic, 1 (disorder) | 2.06e-04 | 4 | 174 | 2 | C3495498 | |
| Disease | Hypertrophic cardiomyopathy 1 | 2.06e-04 | 4 | 174 | 2 | cv:C3495498 | |
| Disease | Caveolinopathy | 2.06e-04 | 4 | 174 | 2 | cv:C5679790 | |
| Disease | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 | 2.06e-04 | 4 | 174 | 2 | 192600 | |
| Disease | acquired metabolic disease (implicated_via_orthology) | 2.06e-04 | 4 | 174 | 2 | DOID:0060158 (implicated_via_orthology) | |
| Disease | Fc receptor-like protein 6 measurement | 2.06e-04 | 4 | 174 | 2 | EFO_0801600 | |
| Disease | neuroimaging measurement | COL5A2 BCL2L14 MYH10 NBEAL1 MARK3 FAT3 MSH5 DCC TG SLC35D1 IGF2BP1 SBNO1 NAV3 ROBO2 RERE PLEC PLCH1 | 2.09e-04 | 1069 | 174 | 17 | EFO_0004346 |
| Disease | Cardiomyopathy, Familial Idiopathic | 2.18e-04 | 50 | 174 | 4 | C1449563 | |
| Disease | Hereditary hearing loss and deafness | 2.36e-04 | 146 | 174 | 6 | cv:C0236038 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 2.48e-04 | 21 | 174 | 3 | EFO_0004286, EFO_0004792 | |
| Disease | Primary familial hypertrophic cardiomyopathy | 2.86e-04 | 22 | 174 | 3 | cv:C0949658 | |
| Disease | hearing impairment | 2.94e-04 | 98 | 174 | 5 | C1384666 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 3.27e-04 | 23 | 174 | 3 | EFO_0004286, EFO_0004791 | |
| Disease | splicing factor 3B subunit 4 measurement | 3.42e-04 | 5 | 174 | 2 | EFO_0803100 | |
| Disease | protein delta homolog 1 measurement | 3.42e-04 | 5 | 174 | 2 | EFO_0801938 | |
| Disease | matrix extracellular phosphoglycoprotein measurement | 3.42e-04 | 5 | 174 | 2 | EFO_0020557 | |
| Disease | brain infarction (is_implicated_in) | 3.42e-04 | 5 | 174 | 2 | DOID:3454 (is_implicated_in) | |
| Disease | Hypertrophic Cardiomyopathy | 3.62e-04 | 57 | 174 | 4 | C0007194 | |
| Disease | CD63 antigen measurement | 5.11e-04 | 6 | 174 | 2 | EFO_0022033 | |
| Disease | serine/threonine-protein kinase ULK3 measurement | 5.11e-04 | 6 | 174 | 2 | EFO_0803065 | |
| Disease | mediator of RNA polymerase II transcription subunit 1 measurement | 5.11e-04 | 6 | 174 | 2 | EFO_0008228 | |
| Disease | progonadoliberin-1 measurement | 5.11e-04 | 6 | 174 | 2 | EFO_0801924 | |
| Disease | BAG family molecular chaperone regulator 4 measurement | 5.11e-04 | 6 | 174 | 2 | EFO_0802303 | |
| Disease | plasma serine protease inhibitor measurement | 5.11e-04 | 6 | 174 | 2 | EFO_0020642 | |
| Disease | glucosidase 2 subunit beta measurement | 5.11e-04 | 6 | 174 | 2 | EFO_0801628 | |
| Disease | Colorectal cancer | 5.31e-04 | 27 | 174 | 3 | cv:C0346629 | |
| Disease | Neoplasm of the large intestine | 5.31e-04 | 27 | 174 | 3 | cv:C0009404 | |
| Disease | COLORECTAL CANCER | 5.31e-04 | 27 | 174 | 3 | 114500 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 6.58e-04 | 29 | 174 | 3 | cv:C5779548 | |
| Disease | cystatin C measurement | 6.71e-04 | 402 | 174 | 9 | EFO_0004617 | |
| Disease | Psychomotor Disorders | 7.12e-04 | 7 | 174 | 2 | C0033922 | |
| Disease | cadherin-15 measurement | 7.12e-04 | 7 | 174 | 2 | EFO_0020211 | |
| Disease | obsolete_interleukin-1 alpha measurement | 7.12e-04 | 7 | 174 | 2 | EFO_0802653 | |
| Disease | Developmental Psychomotor Disorders | 7.12e-04 | 7 | 174 | 2 | C0751456 | |
| Disease | stromal cell-derived factor 1 measurement | 7.12e-04 | 7 | 174 | 2 | EFO_0020756 | |
| Disease | Age related macular degeneration | 7.28e-04 | 30 | 174 | 3 | C0242383 | |
| Disease | D dimer measurement | 7.28e-04 | 30 | 174 | 3 | EFO_0004507 | |
| Disease | factor XI measurement, venous thromboembolism | 7.28e-04 | 30 | 174 | 3 | EFO_0004286, EFO_0004694 | |
| Disease | putamen volume | 8.02e-04 | 31 | 174 | 3 | EFO_0006932 | |
| Disease | autoimmune thyroid disease | 9.25e-04 | 126 | 174 | 5 | EFO_0006812 | |
| Disease | cytoskeleton-associated protein 2 measurement | 9.46e-04 | 8 | 174 | 2 | EFO_0020309 | |
| Disease | alpha-2-macroglobulin measurement | 9.46e-04 | 8 | 174 | 2 | EFO_0020138 | |
| Disease | Aqueductal Stenosis | 9.46e-04 | 8 | 174 | 2 | C2936786 | |
| Disease | neurexophilin-1 measurement | 9.46e-04 | 8 | 174 | 2 | EFO_0008244 | |
| Disease | nemaline myopathy (implicated_via_orthology) | 9.46e-04 | 8 | 174 | 2 | DOID:3191 (implicated_via_orthology) | |
| Disease | sensorineural hearing loss (is_implicated_in) | 9.65e-04 | 33 | 174 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | retinal degeneration (implicated_via_orthology) | 9.65e-04 | 33 | 174 | 3 | DOID:8466 (implicated_via_orthology) | |
| Disease | Retinitis pigmentosa | 9.75e-04 | 74 | 174 | 4 | cv:C0035334 | |
| Disease | FEV/FEC ratio | TSHZ3 MYH9 GIPC2 BANF2 EML4 CAPZB DGKB PRSS23 DCC NEB SLCO1B1 DDX5 ADGRG6 TG USP8 TTC39A ARAP2 | 9.97e-04 | 1228 | 174 | 17 | EFO_0004713 |
| Disease | factor VIII measurement, venous thromboembolism | 1.05e-03 | 34 | 174 | 3 | EFO_0004286, EFO_0004630 | |
| Disease | alcohol consumption measurement | MYH10 SPI1 ARID4A TSHZ2 MARK3 GRID1 DCC SH2B1 PHC2 DMAP1 IGF2BP1 PTPRB RERE ALDH2 CERS1 PLCH1 ARAP2 | 1.13e-03 | 1242 | 174 | 17 | EFO_0007878 |
| Disease | Motor retardation | 1.21e-03 | 9 | 174 | 2 | C0424230 | |
| Disease | alcohol drinking | 1.36e-03 | 81 | 174 | 4 | EFO_0004329 | |
| Disease | Nonsyndromic Deafness | 1.36e-03 | 81 | 174 | 4 | C3711374 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.41e-03 | 447 | 174 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.43e-03 | 139 | 174 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | cyclic AMP-responsive element-binding protein 3-like protein 4 measurement | 1.51e-03 | 10 | 174 | 2 | EFO_0801506 | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.51e-03 | 10 | 174 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.51e-03 | 10 | 174 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | bone morphogenetic protein 7 measurement | 1.51e-03 | 10 | 174 | 2 | EFO_0020187 | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.51e-03 | 10 | 174 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.51e-03 | 10 | 174 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | transmembrane glycoprotein NMB measurement | 1.51e-03 | 10 | 174 | 2 | EFO_0008303 | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.51e-03 | 10 | 174 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.51e-03 | 10 | 174 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | heart disease (is_marker_for) | 1.51e-03 | 10 | 174 | 2 | DOID:114 (is_marker_for) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.51e-03 | 10 | 174 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 1.51e-03 | 10 | 174 | 2 | cv:C5675009 | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.51e-03 | 10 | 174 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 1.58e-03 | 39 | 174 | 3 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | brain measurement, neuroimaging measurement | 1.65e-03 | 550 | 174 | 10 | EFO_0004346, EFO_0004464 | |
| Disease | Disorder of eye | 1.67e-03 | 212 | 174 | 6 | C0015397 | |
| Disease | sphingolipid measurement | 1.70e-03 | 40 | 174 | 3 | EFO_0004622 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.73e-03 | 145 | 174 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Machado-Joseph disease, age at onset | 1.84e-03 | 11 | 174 | 2 | EFO_0004847, MONDO_0007182 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GGSIYQKVNKKLETA | 191 | P21796 | |
| SGIQKTYRKKGENVE | 481 | Q8WWZ7 | |
| QGRYVSFLKQTSGAK | 626 | Q92667 | |
| KGKFGNVYLARLKES | 51 | Q9UQB9 | |
| VKYGRGKTQKIYEAS | 581 | P29374 | |
| KGKFGNVYLAREKQS | 141 | O14965 | |
| KGKNDGTVQGRKYFT | 66 | Q14203 | |
| LVVGIFIGFQKKAYT | 1741 | P78363 | |
| RNYVKQRKAFGKTVA | 311 | P28330 | |
| AKKLINDYVKNGTRG | 176 | P01011 | |
| SIQKKGFNASYIRVA | 136 | Q86SQ4 | |
| QGGFENKKRIDSVYL | 241 | O60443 | |
| FQINKKTGQIYVSGI | 3346 | Q6V0I7 | |
| KKFIRFKNGIITGVY | 41 | P50416 | |
| GKEFQKLVKGIYFNI | 1551 | Q86UQ4 | |
| NRVLGFGTKYLKENF | 291 | Q9BZR8 | |
| NTNSALRYKGKGTGK | 411 | Q92560 | |
| GIQYKTGLGQNKKES | 136 | Q96M93 | |
| ITDNGVGYAFIKRIK | 131 | Q8TF65 | |
| ITDNGAGYAFIKRIK | 126 | Q8TF64 | |
| FNSNVGSKVLGLKYE | 91 | O94923 | |
| LRGYKAKIFTVLSGN | 596 | Q8WZ64 | |
| YQIKVKLTVSGFLGE | 331 | P10523 | |
| NYGRKFVQGKSIDVA | 401 | P08603 | |
| IARFLYKGEGLNKTA | 96 | Q9UIA0 | |
| INVTSKAGGIKKYQE | 796 | Q7Z478 | |
| IYFGKTKDIVNGLRS | 231 | P47756 | |
| GFLFKKLFKYQQTGV | 501 | Q03468 | |
| KSKAIGYLNTGYQRQ | 1001 | P01023 | |
| NKGGKRKQLYSFFTG | 611 | Q6ZS30 | |
| FRGKKLKLYFAQVQT | 76 | Q14206 | |
| KYKGTAFVTLLNGEQ | 91 | Q8IY67 | |
| SGLLVYQGKGKFAIR | 146 | P00387 | |
| DGSYTGFIKVQLKLV | 161 | Q9NS23 | |
| VAYGLYKLKSRGNTK | 41 | Q9Y241 | |
| EGINGKVAYKFRKIN | 271 | Q9Y5G5 | |
| KQFVARYGKVSAGEI | 166 | Q8IXQ6 | |
| GAGKTVNTKRVIQYF | 181 | P12883 | |
| SKKRLSTLKFIGQYG | 86 | Q86VD1 | |
| RKIKVKGYENGNFVG | 386 | Q02252 | |
| ILFYSGTGVRKNKTI | 186 | P47900 | |
| QNGFITGYKIRHRKT | 651 | P43146 | |
| YIKGSADIKSNQGIF | 161 | P49441 | |
| YKIQILTVSGGLFSK | 1061 | P23467 | |
| QKVSFYQLSGKQIGK | 261 | Q9HBG6 | |
| NFSGKGYIIQKREIK | 241 | O60524 | |
| SKNGTVRGVKYKVSA | 101 | A8MXD5 | |
| VRGVKYKVSAGQALF | 106 | A8MXD5 | |
| IKGLFGKKEFLYQTR | 236 | Q5VYY2 | |
| FLGGNEVKSRAVVKY | 41 | Q3B7T1 | |
| EAQFKAQGRIYGKLK | 461 | Q9NZI8 | |
| KITGKQFYKQVTTVG | 256 | Q8N370 | |
| VAFGKGENAKKYLRT | 51 | P10620 | |
| GQGATASVYKARNKK | 16 | Q14164 | |
| GRKFQDEITYGLKKN | 3401 | Q9UPA5 | |
| LLKRDFGAKTQNGVY | 521 | P17844 | |
| RGAFGKVYLAQDIKT | 146 | P41279 | |
| GAGKTENTKKVIQYL | 201 | Q7Z406 | |
| LAKQAFEYGIKKGRQ | 321 | P29122 | |
| KGNTHQYSIFRGILK | 381 | P54315 | |
| GLGKSQKLREISFKY | 216 | Q9UHC1 | |
| SISKGYGRAKDQKSQ | 1921 | Q8IVL0 | |
| GYGKVFQVRKVTGAN | 101 | P23443 | |
| GGYRLFVQKLQDLKK | 431 | P32455 | |
| FLFKVVTKLVNRGYQ | 1786 | Q96RT7 | |
| SGAGKTENTKKVIQY | 176 | P35579 | |
| NGYRLGDKILQVSFK | 306 | Q15717 | |
| KNGELLKYIRKIGSF | 136 | Q6A1A2 | |
| KVNIIQFGTGYKELF | 911 | Q9UKK3 | |
| QGYQVKLAGFELRKT | 341 | Q8NB16 | |
| EAQFKAQGRIYGKIK | 461 | O00425 | |
| KKKINGIFEQLGAYI | 36 | O95140 | |
| TGSNVFGKLRKYVEL | 191 | Q9NUU6 | |
| QLGKGRKKQIYTTDS | 116 | Q9NY74 | |
| LQKGVQFALKYQSLG | 111 | Q8WUK0 | |
| TLKYVAFNGTKVGKQ | 966 | O94856 | |
| GEKVLYSQGVKLFRF | 1056 | A6NKT7 | |
| DIANKGAKQSGLYFI | 181 | P02679 | |
| KGQRGNAYGFKISSL | 826 | Q9Y4D1 | |
| RGIIYNSGEFQKAKK | 286 | Q7L622 | |
| RVYKGNKSFGFTLRG | 281 | A4D2P6 | |
| IEATKQYALGRKKNG | 401 | Q8WV28 | |
| RGYTLQNKSKKGIFP | 46 | Q9H7D0 | |
| VTKGINKAYILLGQF | 36 | Q9H503 | |
| GSGKSQVLKSLNKTY | 2131 | Q9UFH2 | |
| TGQGYRTVKAKLGSK | 76 | Q9NPF5 | |
| YKVKLAAKNSVGSGR | 1451 | Q8TD84 | |
| GILKFFLNQKTVIGY | 6 | Q8N5C1 | |
| RKAIFNIKQLTGGTY | 506 | A8TX70 | |
| IARFLYKGEGLNKTA | 96 | Q99418 | |
| ITYLIRSGNEQGKFK | 3271 | Q8TDW7 | |
| VAQFLYKGEGLNKTV | 101 | O43739 | |
| KSGGKQGERIYRKFQ | 446 | Q9Y6T7 | |
| LEFTKLNIYFKSRGG | 216 | P27544 | |
| SKRNGNVGKTVFEYR | 1451 | P05997 | |
| VFGYKQKGKASVQAI | 3361 | Q99698 | |
| YRLLKTIGKGNFAKV | 56 | P27448 | |
| SKYIDKTIRVKFQGG | 16 | Q9UK45 | |
| FLKGKGIQYSLNVAD | 386 | Q9Y4J8 | |
| SEGIRKAKKGNYAFL | 726 | Q9ULK0 | |
| NSLTRKQGIFGKYEK | 441 | Q9HC35 | |
| KDVESQGRKLGYTFN | 3911 | Q9NYC9 | |
| GQKQGIVRFYGKTDF | 426 | Q96DZ5 | |
| KKRYEVVNGKLTNTG | 256 | Q02742 | |
| VSKKGQSGKVLEYFN | 586 | Q3B820 | |
| VTKNTFRQYRVLGKG | 181 | P34947 | |
| VTKNTFRQYRVLGKG | 181 | P43250 | |
| GQLTYVRSYQGELKK | 366 | Q96RP9 | |
| QLSDRFGRKKVYLTG | 131 | Q8IZD6 | |
| YFGQNKRKGEIAASI | 276 | O75880 | |
| GESQSGGKYKTRLKQ | 406 | A3KN83 | |
| GAGKTENTKKVIQYL | 181 | P35580 | |
| FLNQQAKTIKELGGY | 101 | P0C7X4 | |
| RNQGYDKIIFKGKFV | 196 | Q8N323 | |
| KKVYATSQQIFGAVK | 166 | Q6UXV4 | |
| LDNKTGIKNFKTYGN | 586 | P56715 | |
| SGKSIYLKQVGLITF | 596 | O43196 | |
| KGIVTKFYQLSATGQ | 401 | Q9Y2M0 | |
| GKNKNKFVPYRDSVL | 296 | Q9NQT8 | |
| GEKVLYSQGVKLFRF | 1056 | Q7Z3J3 | |
| RGEYVLTFNFQGKAK | 561 | Q9NRF2 | |
| KFGQGFGKTNIYTQK | 121 | Q9H5V9 | |
| GNYRIQVFTRKGFLK | 391 | Q13049 | |
| QLKQKLQTVGGYTGK | 491 | P0C7P3 | |
| KVTGRFNGQFKTYAI | 41 | P63220 | |
| GKIYQRAFGGQSLKF | 166 | P31040 | |
| KNGLSLLKIGKRNFY | 456 | Q9Y2Z4 | |
| KLVKYLKGGNQTATV | 456 | Q5T2S8 | |
| IYFKSDGKNRLQGFK | 511 | Q7RTY7 | |
| IREGYLVKKGSVFNT | 6 | P08567 | |
| KTYVKGTQKLRVGFL | 181 | O95084 | |
| KEEQKFRYLFQGTKG | 396 | Q16819 | |
| YFGGKLKKTEIQNIE | 416 | Q149N8 | |
| KLREIFGLYGQTTGK | 146 | Q9NR31 | |
| VKRFVKGLRQYGKNF | 401 | Q9P2R6 | |
| KKLTYQFSGEVLGRG | 246 | P17947 | |
| YFGNQITGLFSTKKL | 116 | Q9NTN3 | |
| GAGKTVNTKRVIQYF | 181 | P13533 | |
| NTDVITGLKQKTFYG | 496 | Q9HBY0 | |
| FLGGYIIKKFKLNTV | 391 | Q9Y6L6 | |
| YVISFIFRKGRKNSG | 1121 | O94911 | |
| RYQQLGAGLKVLFKK | 371 | Q9C0B6 | |
| QFKKILGYINTGKQE | 366 | P05091 | |
| RVIIKKGQKGNSFYF | 141 | Q96M20 | |
| LKNTEKIFGVAIYTG | 256 | P98196 | |
| GAGKTENTKKVIQYL | 181 | P35749 | |
| LKNFAGKSLGQIYRV | 16 | Q9P2U8 | |
| VVIKQTGIYAGKKLF | 406 | Q8NHY6 | |
| SLLVGNLKKKYAQGF | 591 | Q8IXK0 | |
| NSKKTRNYIAIDGGK | 121 | Q5W0Q7 | |
| QYTVTLQKDSKRGFG | 31 | Q9UDY2 | |
| AEGGYFGQIRNTKKS | 711 | Q8NI27 | |
| QVTGFKKEYQKVGQS | 456 | Q96RF0 | |
| KKEYQKVGQSFRGLS | 461 | Q96RF0 | |
| KNFGLYVQEKRDGLK | 251 | O95073 | |
| GSRFYGNELKKEKQV | 46 | Q9UBT6 | |
| GYIQKQAQTERKSGK | 196 | P45379 | |
| GIGKVYLKKNRFLEA | 581 | P53804 | |
| GLLNNKVGTFKFIYV | 596 | O94885 | |
| QFLKGLKGVENVYTQ | 451 | Q9NRW7 | |
| KRKGLSNYAVTFQRG | 886 | Q9HCK4 | |
| VVSNYFTKGKRGKRL | 161 | Q6UWH6 | |
| YTGQSVSLFQALKKG | 3246 | Q15149 | |
| ANVKYQLRKTGGTKF | 901 | Q9NRE2 | |
| ANVKYQLRRTGGTKF | 951 | Q63HK5 | |
| QRKIAQYLKGIFGDK | 401 | Q4KWH8 | |
| NIKDSFQKVTLKRYG | 91 | Q03923 | |
| YLKDRGKGNGTLITF | 131 | O60636 | |
| KERSNIYGKTFTLGK | 111 | Q96SR6 | |
| IYGKTFTLGKNRISK | 116 | Q96SR6 | |
| SRNNKYIVTGSGDKK | 721 | Q04725 | |
| VYLKKGQGSTTTLQK | 1676 | P01266 | |
| KGGIKVRNSYQTYKE | 186 | Q5SRH9 | |
| KITIGKINDQFAGYS | 851 | P40818 | |
| NSRILKFGYQFTKQG | 311 | Q9NZR1 | |
| NVKYQLRRTGGTKFL | 946 | Q6ZSZ6 | |
| KILQKGQTAYQRKGS | 346 | Q5VZL5 | |
| KRGLSGKYQTSSKLF | 111 | Q8NBN3 | |
| SSRNKKVGSNKAYLG | 736 | Q96L42 | |
| GQGSYGKVFLVRKVK | 66 | Q15349 | |
| QVFKFSYNKLRVITG | 106 | Q9NR99 | |
| NSSRFGKYIQIGFDK | 216 | Q9ULV0 | |
| SKYRRNGIGTNLVKK | 291 | Q147X3 | |
| NFSSVLYKENLGKGI | 6241 | P20929 |